| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 9.15e-06 | 17 | 162 | 4 | GO:0005132 | |
| GeneOntologyMolecularFunction | kinase binding | TOM1L2 IL12RB2 FMR1 WARS1 WWC3 PPP1R12B TNS2 GCKR RGS14 KAT2B LDB3 PTPRF SIPA1L1 SMO LRRC7 CEP152 NBR1 BANK1 TOP2A HTT | 1.17e-04 | 969 | 162 | 20 | GO:0019900 |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 1.95e-04 | 3 | 162 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 1.95e-04 | 3 | 162 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | myosin VI binding | 1.95e-04 | 3 | 162 | 2 | GO:0070853 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 3.88e-04 | 4 | 162 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.99e-04 | 127 | 162 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | kinase inhibitor activity | 6.78e-04 | 86 | 162 | 5 | GO:0019210 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 7.21e-04 | 22 | 162 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | protein kinase binding | TOM1L2 IL12RB2 FMR1 WARS1 PPP1R12B TNS2 RGS14 KAT2B LDB3 PTPRF SIPA1L1 SMO LRRC7 CEP152 NBR1 BANK1 TOP2A | 7.53e-04 | 873 | 162 | 17 | GO:0019901 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | XRN2 WARS1 DHX38 WRNIP1 SPO11 CHD3 VARS2 ZRANB3 HELB MRM3 MBLAC1 PDE12 RNASE10 TOP2A | 7.99e-04 | 645 | 162 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | CDKN1C COL7A1 WARS1 PPP1R12B LMTK2 GCKR APOC3 SERPINA6 KAT2B AGT SMO | 8.70e-04 | 435 | 162 | 11 | GO:0004857 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 9.36e-04 | 24 | 162 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.06e-03 | 25 | 162 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | CDKN1C COL7A1 WARS1 PPP1R12B LMTK2 GCKR APOC3 SERPINA6 KAT2B AGT NFKBIL1 FNIP1 SMO | 1.17e-03 | 596 | 162 | 13 | GO:0140678 |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.33e-03 | 27 | 162 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX38 WRNIP1 PEX1 SPO11 ABCC9 CHD3 ZRANB3 HELB MDN1 STARD9 TOP2A ABCC10 DYNC1I1 | 1.53e-03 | 614 | 162 | 13 | GO:0140657 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.88e-05 | 21 | 160 | 4 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 3.28e-05 | 24 | 160 | 4 | GO:0033139 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 CDKN1C CNTN4 FAT4 ARHGEF28 FMR1 SZT2 PACSIN1 DDR2 APBB1 DOCK10 LMTK2 PLXND1 CUL7 POSTN KAT2B ALMS1 PTPRF SIPA1L1 AGT CAPRIN2 SMO LRRC7 RP1 HTT EPHB1 | 5.96e-05 | 1463 | 160 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 6.14e-05 | 54 | 160 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 6.18e-05 | 28 | 160 | 4 | GO:0042501 | |
| GeneOntologyBiologicalProcess | microtubule-based process | XRN2 FMR1 KIAA0319L PEX1 CHD3 CUL7 MREG RGS14 KAT2B ALMS1 STARD9 RNASE10 TLE6 TEKT1 TXNDC9 CEP152 RP1 AP3D1 DYNC1I1 HTT NLRP5 | 7.19e-05 | 1058 | 160 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | cellular response to virus | 7.22e-05 | 90 | 160 | 6 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.29e-04 | 63 | 160 | 5 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.29e-04 | 63 | 160 | 5 | GO:0050691 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | FMR1 PACSIN1 DDR2 APBB1 PLXND1 CUL7 KAT2B PTPRF AGT CAPRIN2 LRRC7 RP1 HTT | 1.31e-04 | 494 | 160 | 13 | GO:0031346 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 1.37e-04 | 101 | 160 | 6 | GO:0033138 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 CNTN4 FAT4 ARHGEF28 FMR1 SZT2 PACSIN1 DDR2 APBB1 DOCK10 LMTK2 PLXND1 CUL7 POSTN KAT2B ALMS1 PTPRF SIPA1L1 AGT CAPRIN2 SMO LRRC7 EPHB1 | 1.50e-04 | 1285 | 160 | 23 | GO:0031175 |
| Domain | LRRC37AB_C | 2.69e-06 | 4 | 165 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.69e-06 | 4 | 165 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.69e-06 | 4 | 165 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.69e-06 | 4 | 165 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.69e-06 | 4 | 165 | 3 | IPR015753 | |
| Domain | - | 3.69e-06 | 73 | 165 | 7 | 2.60.120.260 | |
| Domain | Interferon | 1.28e-05 | 17 | 165 | 4 | PF00143 | |
| Domain | INTERFERON_A_B_D | 1.28e-05 | 17 | 165 | 4 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 1.28e-05 | 17 | 165 | 4 | IPR000471 | |
| Domain | IFabd | 1.28e-05 | 17 | 165 | 4 | SM00076 | |
| Domain | Galactose-bd-like | 1.99e-05 | 94 | 165 | 7 | IPR008979 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.27e-04 | 138 | 165 | 7 | IPR001245 | |
| Domain | TOM1 | 2.31e-04 | 3 | 165 | 2 | IPR014645 | |
| Domain | PDEase_N | 2.31e-04 | 3 | 165 | 2 | IPR013706 | |
| Domain | PDEase_I_N | 2.31e-04 | 3 | 165 | 2 | PF08499 | |
| Domain | FN3_dom | 5.50e-04 | 209 | 165 | 8 | IPR003961 | |
| Domain | PDEase | 5.91e-04 | 19 | 165 | 3 | IPR023088 | |
| Domain | PDEase_I | 8.01e-04 | 21 | 165 | 3 | PF00233 | |
| Domain | PDEASE_I | 8.01e-04 | 21 | 165 | 3 | PS00126 | |
| Domain | PDEase_CS | 8.01e-04 | 21 | 165 | 3 | IPR023174 | |
| Domain | - | 9.22e-04 | 22 | 165 | 3 | 1.10.1300.10 | |
| Domain | - | 9.86e-04 | 50 | 165 | 4 | 1.20.1250.10 | |
| Domain | Pkinase_Tyr | 1.01e-03 | 129 | 165 | 6 | PF07714 | |
| Domain | PDEase_catalytic_dom | 1.05e-03 | 23 | 165 | 3 | IPR002073 | |
| Domain | 4_helix_cytokine_core | 1.06e-03 | 51 | 165 | 4 | IPR012351 | |
| Domain | GAT_dom | 1.14e-03 | 6 | 165 | 2 | IPR004152 | |
| Domain | - | 1.14e-03 | 6 | 165 | 2 | 1.20.58.160 | |
| Domain | GAT | 1.14e-03 | 6 | 165 | 2 | PS50909 | |
| Domain | GAT | 1.14e-03 | 6 | 165 | 2 | PF03127 | |
| Domain | HD/PDEase_dom | 1.20e-03 | 24 | 165 | 3 | IPR003607 | |
| Domain | HDc | 1.20e-03 | 24 | 165 | 3 | SM00471 | |
| Domain | FN3 | 1.30e-03 | 185 | 165 | 7 | SM00060 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 9.22e-06 | 35 | 116 | 5 | M6382 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 9.54e-06 | 17 | 116 | 4 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.22e-05 | 18 | 116 | 4 | M47539 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.22e-05 | 37 | 116 | 5 | M39785 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.53e-05 | 19 | 116 | 4 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.53e-05 | 19 | 116 | 4 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.90e-05 | 20 | 116 | 4 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 2.34e-05 | 21 | 116 | 4 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 2.84e-05 | 22 | 116 | 4 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 2.84e-05 | 22 | 116 | 4 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 3.42e-05 | 23 | 116 | 4 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.42e-05 | 23 | 116 | 4 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 4.07e-05 | 24 | 116 | 4 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 4.07e-05 | 24 | 116 | 4 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 4.07e-05 | 24 | 116 | 4 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 5.66e-05 | 26 | 116 | 4 | M982 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 7.65e-05 | 28 | 116 | 4 | MM1378 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.01e-04 | 30 | 116 | 4 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.15e-04 | 31 | 116 | 4 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.15e-04 | 31 | 116 | 4 | M47964 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.48e-04 | 33 | 116 | 4 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.67e-04 | 34 | 116 | 4 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.87e-04 | 35 | 116 | 4 | M48246 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.87e-04 | 39 | 116 | 4 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 3.49e-04 | 41 | 116 | 4 | MM1493 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 5.44e-04 | 46 | 116 | 4 | M48105 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 8.69e-04 | 52 | 116 | 4 | M13103 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 9.85e-04 | 6 | 116 | 2 | MM14494 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.07e-03 | 55 | 116 | 4 | M39763 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.07e-03 | 55 | 116 | 4 | M11844 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES STIM2 ARHGEF28 HJURP APBB1 ANKRD26 LMTK2 KIAA1671 RADIL BMX MDN1 ALMS1 SYNJ1 STARD9 SIPA1L1 EIF4B FNIP1 CEP152 SSH2 GAB1 CCDC102A | 1.52e-09 | 861 | 169 | 21 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 PDE4A B4GALNT4 SZT2 UBE3B UBR4 KIAA0319L AKNA LMTK2 TTYH3 PLXND1 IFNLR1 ARHGEF10L RADIL MDN1 PTPRF MROH6 SYNJ1 ZNF839 GCN1 AP3D1 ABCC10 HTT | 4.81e-09 | 1105 | 169 | 23 | 35748872 |
| Pubmed | 4.93e-09 | 14 | 169 | 5 | 22815848 | ||
| Pubmed | CNTN4 STIM2 ARHGEF28 DHX38 PTDSS1 ANKRD26 TTYH3 VARS2 CUL7 RADIL LDB3 ALMS1 CEP152 SSH2 KLHL18 | 2.18e-08 | 493 | 169 | 15 | 15368895 | |
| Pubmed | 1.73e-07 | 11 | 169 | 4 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.73e-07 | 11 | 169 | 4 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.73e-07 | 11 | 169 | 4 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.73e-07 | 11 | 169 | 4 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.73e-07 | 11 | 169 | 4 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.73e-07 | 11 | 169 | 4 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.73e-07 | 11 | 169 | 4 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.73e-07 | 11 | 169 | 4 | 15795237 | |
| Pubmed | 1.73e-07 | 11 | 169 | 4 | 9794439 | ||
| Pubmed | 1.73e-07 | 11 | 169 | 4 | 25310498 | ||
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 1.89e-07 | 27 | 169 | 5 | 30936491 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 2.58e-07 | 12 | 169 | 4 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 2.58e-07 | 12 | 169 | 4 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 2.58e-07 | 12 | 169 | 4 | 27988795 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 2.58e-07 | 12 | 169 | 4 | 17512142 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 9425112 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 2.58e-07 | 12 | 169 | 4 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 2.58e-07 | 12 | 169 | 4 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 2.58e-07 | 12 | 169 | 4 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 2.58e-07 | 12 | 169 | 4 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 2.58e-07 | 12 | 169 | 4 | 7684767 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 2.58e-07 | 12 | 169 | 4 | 26277892 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 2.58e-07 | 12 | 169 | 4 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 2.58e-07 | 12 | 169 | 4 | 16611902 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 30967261 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 2.58e-07 | 12 | 169 | 4 | 22912583 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 23747509 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 17434974 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 2.58e-07 | 12 | 169 | 4 | 3758677 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 19406830 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 8245849 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 22685550 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 3017340 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 2.58e-07 | 12 | 169 | 4 | 8304945 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 2.58e-07 | 12 | 169 | 4 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 2.58e-07 | 12 | 169 | 4 | 1422836 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 2.58e-07 | 12 | 169 | 4 | 7530016 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 17277125 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 2.58e-07 | 12 | 169 | 4 | 1360280 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 17451966 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 2.58e-07 | 12 | 169 | 4 | 8672140 | |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 7601556 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 3.72e-07 | 13 | 169 | 4 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 3.72e-07 | 13 | 169 | 4 | 2014240 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 18005734 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 3.72e-07 | 13 | 169 | 4 | 6094686 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 2993652 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 1655578 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 2471809 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 21263073 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 8438572 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 38660315 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 3.72e-07 | 13 | 169 | 4 | 23255800 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 7523540 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 19635904 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 19706714 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 23804712 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 3.72e-07 | 13 | 169 | 4 | 3973562 | |
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 3.72e-07 | 13 | 169 | 4 | 2987810 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 19130550 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 21469099 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 22739040 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 20065291 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 3.72e-07 | 13 | 169 | 4 | 9865497 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 9181467 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 17723216 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 3.72e-07 | 13 | 169 | 4 | 18726328 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 18572754 | ||
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 15723075 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 22419166 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 5.19e-07 | 14 | 169 | 4 | 18981154 | |
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 5.19e-07 | 14 | 169 | 4 | 8668211 | |
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 19620305 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 5.19e-07 | 14 | 169 | 4 | 7526537 | |
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 19559726 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 15240719 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 16418394 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 18272764 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 11884139 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 19004943 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 5.19e-07 | 14 | 169 | 4 | 7654369 | |
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 5.19e-07 | 14 | 169 | 4 | 7532202 | |
| Cytoband | 9p22 | 2.11e-06 | 25 | 169 | 4 | 9p22 | |
| Cytoband | 17q21.31 | 2.48e-04 | 82 | 169 | 4 | 17q21.31 | |
| GeneFamily | Interferons | 3.04e-05 | 32 | 102 | 4 | 598 | |
| GeneFamily | Fibronectin type III domain containing | 2.92e-04 | 160 | 102 | 6 | 555 | |
| GeneFamily | Phosphodiesterases | 3.24e-04 | 24 | 102 | 3 | 681 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.48e-03 | 40 | 102 | 3 | 321 | |
| GeneFamily | Sterile alpha motif domain containing | 1.55e-03 | 88 | 102 | 4 | 760 | |
| GeneFamily | PDZ domain containing | 1.70e-03 | 152 | 102 | 5 | 1220 | |
| GeneFamily | ATP binding cassette subfamily C | 2.36e-03 | 13 | 102 | 2 | 807 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.74e-03 | 14 | 102 | 2 | 1095 | |
| GeneFamily | AAA ATPases | 3.33e-03 | 53 | 102 | 3 | 413 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 5.06e-03 | 19 | 102 | 2 | 131 | |
| GeneFamily | Regulators of G-protein signaling | 6.17e-03 | 21 | 102 | 2 | 720 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 1.89e-05 | 85 | 169 | 6 | MM684 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 2.01e-05 | 128 | 169 | 7 | M1966 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | TOM1L2 CDKN1C APBB1 ANKS1B DOCK10 TNS2 AGPS LDB3 FNIP1 ATG4C TXNDC9 SSH2 QDPR NBR1 FAM131B GAB1 | 3.21e-05 | 754 | 169 | 16 | M39037 |
| Coexpression | GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN | 3.27e-05 | 189 | 169 | 8 | M7266 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 3.49e-05 | 29 | 169 | 4 | MM586 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 3.92e-05 | 142 | 169 | 7 | MM840 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP | 4.71e-05 | 199 | 169 | 8 | M8390 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 4.71e-05 | 199 | 169 | 8 | M5182 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP | 4.71e-05 | 199 | 169 | 8 | M5213 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | TOM1L2 CNTN4 PDE1C B4GALNT4 FMR1 VARS2 MDN1 LRRC7 GCN1 FAM131B DYNC1I1 | 4.76e-05 | 389 | 169 | 11 | M39102 |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN | 4.88e-05 | 200 | 169 | 8 | M8398 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 4.88e-05 | 200 | 169 | 8 | M6537 | |
| Coexpression | GSE7831_1H_VS_4H_CPG_STIM_PDC_UP | 4.88e-05 | 200 | 169 | 8 | M6960 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN | 9.02e-05 | 162 | 169 | 7 | M8827 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 9.82e-05 | 221 | 169 | 8 | M39222 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.15e-04 | 39 | 169 | 4 | M41095 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 1.18e-04 | 74 | 169 | 5 | M515 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.80e-07 | 186 | 169 | 8 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.95e-07 | 197 | 169 | 8 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-06 | 166 | 169 | 7 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-06 | 166 | 169 | 7 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 167 | 169 | 7 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 167 | 169 | 7 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.50e-06 | 183 | 169 | 7 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-06 | 186 | 169 | 7 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-06 | 186 | 169 | 7 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 7.48e-06 | 187 | 169 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 7.48e-06 | 187 | 169 | 7 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 8.30e-06 | 190 | 169 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-06 | 190 | 169 | 7 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.59e-06 | 191 | 169 | 7 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.59e-06 | 191 | 169 | 7 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 199 | 169 | 7 | 598937913fe1f12d741fa49e23ae195a7be5cbe3 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 163 | 169 | 6 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 163 | 169 | 6 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass | 3.88e-05 | 164 | 169 | 6 | 06db4cc064f0765c481ce880207823872c27bfa9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.59e-05 | 169 | 169 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 173 | 169 | 6 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.22e-05 | 173 | 169 | 6 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 173 | 169 | 6 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 174 | 169 | 6 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 174 | 169 | 6 | ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.39e-05 | 174 | 169 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 174 | 169 | 6 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 176 | 169 | 6 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.93e-05 | 177 | 169 | 6 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 178 | 169 | 6 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-05 | 179 | 169 | 6 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-05 | 179 | 169 | 6 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-05 | 179 | 169 | 6 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | 09a574a3257e25c8b05a2ab20623a6b07331411a | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | ac4142aa93706b7067f63d2d38e2456859e60768 | |
| ToppCell | Adult-Immune-natural_killer_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.92e-05 | 182 | 169 | 6 | dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.13e-05 | 183 | 169 | 6 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 183 | 169 | 6 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 183 | 169 | 6 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 7.35e-05 | 184 | 169 | 6 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-05 | 184 | 169 | 6 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 185 | 169 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.57e-05 | 185 | 169 | 6 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.57e-05 | 185 | 169 | 6 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 185 | 169 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.80e-05 | 186 | 169 | 6 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.80e-05 | 186 | 169 | 6 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-05 | 186 | 169 | 6 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.80e-05 | 186 | 169 | 6 | 86b218a400f9c64f92b050f00b49f09647b17437 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.80e-05 | 186 | 169 | 6 | f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-05 | 186 | 169 | 6 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.03e-05 | 187 | 169 | 6 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-05 | 187 | 169 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-05 | 187 | 169 | 6 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.03e-05 | 187 | 169 | 6 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-05 | 187 | 169 | 6 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-05 | 188 | 169 | 6 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-05 | 188 | 169 | 6 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-05 | 189 | 169 | 6 | cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-05 | 189 | 169 | 6 | 102501eee7760d5882dec41ea9d00147b3f4fb73 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | d00410010283dc6191ce9857d6c7952678fed588 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 8.52e-05 | 189 | 169 | 6 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-05 | 189 | 169 | 6 | 6e83bf855d4771885b60bb8992df2f9b508eef97 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 190 | 169 | 6 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 190 | 169 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.77e-05 | 190 | 169 | 6 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 190 | 169 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.77e-05 | 190 | 169 | 6 | 251d50a77e5118a9ad19ea01a7c7c862230ed63c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 190 | 169 | 6 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.02e-05 | 191 | 169 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.02e-05 | 191 | 169 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 9.02e-05 | 191 | 169 | 6 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-05 | 192 | 169 | 6 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 39afea574725ce0c67afdd79facdb34f819a828d | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 597db951b1fbc37db22134c3d27d3ec4ceaa85f7 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | bc275a9eccb1c7a46fd58b15ca5acdd9f7495842 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-05 | 192 | 169 | 6 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 193 | 169 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 193 | 169 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 193 | 169 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 9.55e-05 | 193 | 169 | 6 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 9.55e-05 | 193 | 169 | 6 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.55e-05 | 193 | 169 | 6 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.83e-05 | 194 | 169 | 6 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 9.83e-05 | 194 | 169 | 6 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 195 | 169 | 6 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 196 | 169 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-04 | 196 | 169 | 6 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-04 | 196 | 169 | 6 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 196 | 169 | 6 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 196 | 169 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 197 | 169 | 6 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 197 | 169 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 197 | 169 | 6 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 197 | 169 | 6 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 197 | 169 | 6 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 197 | 169 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.07e-04 | 197 | 169 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 198 | 169 | 6 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| Drug | Yfrkd | 9.84e-08 | 7 | 168 | 4 | CID000129984 | |
| Drug | bromcresol green | 1.28e-07 | 110 | 168 | 9 | CID000006451 | |
| Drug | 1hiv | 1.96e-07 | 8 | 168 | 4 | CID005479205 | |
| Drug | Chebi:36708 | 1.96e-07 | 8 | 168 | 4 | CID011966289 | |
| Drug | pipobroman | 5.80e-07 | 10 | 168 | 4 | CID000004842 | |
| Drug | flesinoxan | 9.07e-07 | 11 | 168 | 4 | CID000057347 | |
| Drug | barium iodide | 1.57e-06 | 4 | 168 | 3 | CID000083684 | |
| Drug | R 842 | 1.94e-06 | 13 | 168 | 4 | CID000130714 | |
| Drug | AC1O52EF | 1.94e-06 | 13 | 168 | 4 | CID006450817 | |
| Drug | DTIC | 2.31e-06 | 81 | 168 | 7 | CID005281007 | |
| Drug | Lanicemine | 2.70e-06 | 14 | 168 | 4 | CID003038485 | |
| Drug | gunacin | 2.70e-06 | 14 | 168 | 4 | CID000198547 | |
| Drug | CHEMBL466993 | 3.53e-06 | 32 | 168 | 5 | CID005320808 | |
| Drug | pppA2'-5'A2'-5'A | 3.66e-06 | 15 | 168 | 4 | CID000125229 | |
| Drug | B132 | 3.90e-06 | 5 | 168 | 3 | CID002734031 | |
| Drug | YNK01 | 6.32e-06 | 17 | 168 | 4 | CID000084071 | |
| Drug | HCV-371 | 7.77e-06 | 6 | 168 | 3 | CID003013096 | |
| Drug | p203 | 8.07e-06 | 18 | 168 | 4 | CID000019228 | |
| Drug | podophyllin | 8.07e-06 | 18 | 168 | 4 | CID011979494 | |
| Drug | Nyco | 8.07e-06 | 18 | 168 | 4 | CID000071618 | |
| Drug | isofagomine lactam | 9.68e-06 | 39 | 168 | 5 | CID000448980 | |
| Drug | Ciluprevir [USAN] | 1.26e-05 | 20 | 168 | 4 | CID006450803 | |
| Drug | val-mCyd | 1.26e-05 | 20 | 168 | 4 | CID006918726 | |
| Drug | L DO | 1.55e-05 | 21 | 168 | 4 | CID000097725 | |
| Drug | Murabutida | 1.58e-05 | 43 | 168 | 5 | CID005362018 | |
| Drug | WY-14643; Down 200; 100uM; MCF7; HG-U133A | 1.70e-05 | 198 | 168 | 9 | 368_DN | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 4087_DN | |
| Drug | formosanin C | 1.89e-05 | 22 | 168 | 4 | CID000073597 | |
| Drug | AC1LAD6M | 2.15e-05 | 8 | 168 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 2.15e-05 | 8 | 168 | 3 | CID010011375 | |
| Drug | AC1L9AL3 | 2.21e-05 | 46 | 168 | 5 | CID000441122 | |
| Drug | Hiltonol | 2.27e-05 | 23 | 168 | 4 | CID000431963 | |
| Drug | AC1L1ZCT | 2.71e-05 | 24 | 168 | 4 | CID000038235 | |
| Drug | cycloferon | 2.71e-05 | 24 | 168 | 4 | CID000038072 | |
| Drug | NSC289637 | 2.73e-05 | 48 | 168 | 5 | CID000004213 | |
| Drug | hycanthone | 3.21e-05 | 25 | 168 | 4 | CID000003634 | |
| Drug | LB80380 | 3.21e-05 | 25 | 168 | 4 | CID006480442 | |
| Drug | Telaprevir | 3.21e-05 | 9 | 168 | 3 | CID003010818 | |
| Drug | boceprevir | 3.21e-05 | 9 | 168 | 3 | CID010324367 | |
| Drug | ABMP | 3.77e-05 | 26 | 168 | 4 | CID000080567 | |
| Drug | famciclovir | 4.05e-05 | 52 | 168 | 5 | CID000003324 | |
| Drug | inosiplex | 4.40e-05 | 27 | 168 | 4 | CID000037510 | |
| Drug | VX-497 | 4.40e-05 | 27 | 168 | 4 | CID000153241 | |
| Drug | AC1NRD2B | 5.10e-05 | 28 | 168 | 4 | CID005289317 | |
| Drug | NSC229609 | 5.41e-05 | 2 | 168 | 2 | CID000069530 | |
| Drug | NSC141633 | 5.88e-05 | 29 | 168 | 4 | CID000003628 | |
| Drug | NM 108 | 5.88e-05 | 29 | 168 | 4 | CID000500901 | |
| Drug | SC-57099B | 6.23e-05 | 11 | 168 | 3 | CID000178079 | |
| Drug | penciclovir | 6.75e-05 | 30 | 168 | 4 | CID000004725 | |
| Drug | DZNep | 6.75e-05 | 30 | 168 | 4 | CID000073087 | |
| Drug | poly rI:rC | 6.75e-05 | 30 | 168 | 4 | CID011979660 | |
| Drug | 2-nitroaniline | 7.92e-05 | 139 | 168 | 7 | CID000006946 | |
| Drug | casopitant | 8.27e-05 | 12 | 168 | 3 | CID009917021 | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 2893_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 2924_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 7377_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 1.07e-04 | 196 | 168 | 8 | 2441_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 168 | 8 | 4283_UP | |
| Drug | AC1L1HZP | 1.11e-04 | 64 | 168 | 5 | CID000004361 | |
| Drug | adefovir | 1.11e-04 | 64 | 168 | 5 | CID000060172 | |
| Drug | 5H-purin-2-amine | 1.11e-04 | 102 | 168 | 6 | CID000409844 | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; HL60; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 3094_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; HL60; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 2151_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 3478_DN | |
| Drug | carprofen | 1.12e-04 | 34 | 168 | 4 | CID000002581 | |
| Drug | oxymatrine | 1.12e-04 | 34 | 168 | 4 | CID000114850 | |
| Drug | tenofovir disoproxil fumarate | 1.12e-04 | 34 | 168 | 4 | CID005481350 | |
| Drug | emtricitabine | 1.13e-04 | 147 | 168 | 7 | CID000060877 | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 7010_DN | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 6137_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; PC3; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 4550_UP | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 4435_UP | |
| Drug | tilorone | 1.25e-04 | 35 | 168 | 4 | CID000005475 | |
| Drug | lobucavir | 1.25e-04 | 35 | 168 | 4 | CID000060786 | |
| Drug | AC1O51IP | 1.28e-04 | 66 | 168 | 5 | CID006450363 | |
| Drug | copolymer 1 | 1.28e-04 | 66 | 168 | 5 | CID003081884 | |
| Drug | MCNU | 1.40e-04 | 36 | 168 | 4 | CID000071741 | |
| Drug | A809128 | 1.40e-04 | 36 | 168 | 4 | CID003392279 | |
| Drug | pyran | 1.56e-04 | 37 | 168 | 4 | CID000033703 | |
| Drug | FMAU | 1.56e-04 | 37 | 168 | 4 | CID000072327 | |
| Drug | 2-[amino-[(2R,3R)-4-(dibenzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 1.56e-04 | 37 | 168 | 4 | CID016040231 | |
| Drug | cycloleucine | 1.58e-04 | 69 | 168 | 5 | CID000002901 | |
| Drug | 21-dehydrocortisol | 1.62e-04 | 3 | 168 | 2 | CID000225755 | |
| Drug | AC1LCVPZ | 1.68e-04 | 110 | 168 | 6 | CID000656926 | |
| Drug | anagrelide | 1.74e-04 | 38 | 168 | 4 | CID000002182 | |
| Drug | fotemustine | 1.74e-04 | 38 | 168 | 4 | CID000104799 | |
| Drug | dipyridamole | 2.05e-04 | 162 | 168 | 7 | CID000003108 | |
| Drug | AC1L1GHH | 2.20e-04 | 74 | 168 | 5 | CID000003685 | |
| Drug | p-nitrophenyl-alpha-D-glucopyranoside | 2.24e-04 | 116 | 168 | 6 | CID000065115 | |
| Drug | dideoxyinosine | 2.34e-04 | 75 | 168 | 5 | CID000003043 | |
| Drug | 2',3'-dideoxycytidine (ddC | 2.49e-04 | 76 | 168 | 5 | CID000005718 | |
| Drug | 1 ind | 2.57e-04 | 42 | 168 | 4 | CID003037877 | |
| Drug | TORCH | 2.65e-04 | 77 | 168 | 5 | CID000015531 | |
| Drug | AC1MMF4B | 2.65e-04 | 77 | 168 | 5 | CID003260010 | |
| Drug | AC1NRBRB | 2.82e-04 | 43 | 168 | 4 | CID005288597 | |
| Drug | NSC 312887 | 2.82e-04 | 43 | 168 | 4 | CID000003368 | |
| Drug | Sesquimustard | 2.82e-04 | 43 | 168 | 4 | CID000019092 | |
| Drug | AC1L1J7E | 2.86e-04 | 171 | 168 | 7 | CID000004900 | |
| Disease | hyperinsulinism (is_implicated_in) | 3.38e-05 | 12 | 161 | 3 | DOID:2018 (is_implicated_in) | |
| Disease | bilirubin measurement | 1.67e-04 | 442 | 161 | 10 | EFO_0004570 | |
| Disease | inflammatory bowel disease | IL12RB2 ZC3H13 UBR4 TOM1 GCKR UBASH3A RGS14 FADS2 PRRC2A BANK1 | 1.90e-04 | 449 | 161 | 10 | EFO_0003767 |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.61e-04 | 23 | 161 | 3 | OBA_2045158 | |
| Disease | 1-myristoyl-2-linoleoyl-GPC (14:0/18:2) measurement | 2.93e-04 | 5 | 161 | 2 | EFO_0800452 | |
| Disease | alpha-linolenic acid measurement | 3.36e-04 | 25 | 161 | 3 | EFO_0007759 | |
| Disease | 3-hydroxybutyrate measurement | 3.36e-04 | 25 | 161 | 3 | EFO_0010982 | |
| Disease | diacylglycerol 34:2 measurement | 3.36e-04 | 25 | 161 | 3 | EFO_0010353 | |
| Disease | urate measurement | COL7A1 DHX38 DDR2 LMTK2 CHD3 GCKR VARS2 CHRNA5 RGS14 PTPRF C11orf68 SLC28A1 FADS2 BANK1 | 4.14e-04 | 895 | 161 | 14 | EFO_0004531 |
| Disease | docosapentaenoic acid measurement | 4.24e-04 | 27 | 161 | 3 | EFO_0006809 | |
| Disease | gondoic acid measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0007975 | |
| Disease | triacylglycerol 54:7 measurement | 4.72e-04 | 28 | 161 | 3 | EFO_0010425 | |
| Disease | cholesteryl ester 24:4 measurement | 6.10e-04 | 7 | 161 | 2 | EFO_0021447 | |
| Disease | Antihypertensive use measurement | 6.56e-04 | 265 | 161 | 7 | EFO_0009927 | |
| Disease | Large cell carcinoma of lung | 7.04e-04 | 32 | 161 | 3 | C0345958 | |
| Disease | apolipoprotein A 1 measurement | COL7A1 ARHGEF28 DHX38 AKNA GCKR APOC3 ZRANB3 LDB3 PDGFD FADS2 ATG4C BANK1 CCDC102A | 8.02e-04 | 848 | 161 | 13 | EFO_0004614 |
| Disease | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement | 8.11e-04 | 8 | 161 | 2 | EFO_0800455 | |
| Disease | Malignant neoplasm of breast | COL7A1 WARS1 ANK1 PPP1R12B UBR4 LRRC37A2 LRRC37A OTOF SIPA1L1 SLC28A1 LRRC7 ENPEP PRRC2A TOP2A GAB1 | 8.30e-04 | 1074 | 161 | 15 | C0006142 |
| Disease | phosphatidylcholine 32:1 measurement | 1.17e-03 | 38 | 161 | 3 | EFO_0010373 | |
| Disease | obesity (implicated_via_orthology) | 1.20e-03 | 215 | 161 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 1.29e-03 | 10 | 161 | 2 | EFO_0800608 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 1.29e-03 | 10 | 161 | 2 | EFO_0800507 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 1.29e-03 | 10 | 161 | 2 | EFO_0800464 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 1.29e-03 | 10 | 161 | 2 | OBA_2045193 | |
| Disease | level of phosphatidylcholine | 1.29e-03 | 10 | 161 | 2 | OBA_2040179 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.58e-03 | 11 | 161 | 2 | EFO_0800269 | |
| Disease | mean arterial pressure | 1.75e-03 | 499 | 161 | 9 | EFO_0006340 | |
| Disease | platelet measurement | 1.78e-03 | 315 | 161 | 7 | EFO_0005036 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0010378 | |
| Disease | triacylglycerol 53:2 measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0021484 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0800453 | |
| Disease | cholesteryl ester 24:5 measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0021448 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 1.88e-03 | 12 | 161 | 2 | OBA_2045074 | |
| Disease | QRS complex, QRS duration | 1.91e-03 | 45 | 161 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | smoking cessation | 2.12e-03 | 325 | 161 | 7 | EFO_0004319 | |
| Disease | autism spectrum disorder, schizophrenia | 2.19e-03 | 327 | 161 | 7 | EFO_0003756, MONDO_0005090 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 2.22e-03 | 13 | 161 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 2.22e-03 | 13 | 161 | 2 | OBA_2045082 | |
| Disease | sleep duration, triglyceride measurement | 2.57e-03 | 104 | 161 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | 1-methylurate measurement | 2.58e-03 | 14 | 161 | 2 | EFO_0021173 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 2.58e-03 | 14 | 161 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 2.58e-03 | 14 | 161 | 2 | OBA_2045143 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.59e-03 | 50 | 161 | 3 | EFO_0022303 | |
| Disease | phosphatidylethanolamine measurement | 2.65e-03 | 173 | 161 | 5 | EFO_0010228 | |
| Disease | Nephrosis | 2.97e-03 | 15 | 161 | 2 | C0027720 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 2.97e-03 | 15 | 161 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | tumor necrosis factor measurement | 2.97e-03 | 15 | 161 | 2 | EFO_0010834 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 2.97e-03 | 15 | 161 | 2 | OBA_2045165 | |
| Disease | lung small cell carcinoma (is_marker_for) | 3.38e-03 | 16 | 161 | 2 | DOID:5409 (is_marker_for) | |
| Disease | vitamin C measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0600003 | |
| Disease | phosphatidylcholine 32:2 measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0010374 | |
| Disease | diacylglycerol 36:2 measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0010355 | |
| Disease | level of Sterol ester (27:1/18:0) in blood serum | 3.38e-03 | 16 | 161 | 2 | OBA_2045196 | |
| Disease | diacylglycerol 44:7 measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0020069 | |
| Disease | response to acetylsalicylate | 3.38e-03 | 16 | 161 | 2 | GO_1903492 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 3.40e-03 | 55 | 161 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 3.58e-03 | 56 | 161 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | apolipoprotein B measurement | 3.59e-03 | 663 | 161 | 10 | EFO_0004615 | |
| Disease | erythritol measurement | 3.81e-03 | 17 | 161 | 2 | EFO_0021171 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 3.81e-03 | 17 | 161 | 2 | OBA_2045063 | |
| Disease | response to carboplatin | 3.95e-03 | 58 | 161 | 3 | GO_0097328 | |
| Disease | serum urea measurement | 4.42e-03 | 195 | 161 | 5 | EFO_0009795 | |
| Disease | chronic obstructive pulmonary disease | ARHGEF28 PPP1R12B LRRC37A2 DOCK10 VARS2 CHRNA5 NFKBIL1 RASGEF1C SSH2 SPPL2C | 4.65e-03 | 688 | 161 | 10 | EFO_0000341 |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 4.76e-03 | 19 | 161 | 2 | OBA_2045140 | |
| Disease | ovulation | 4.76e-03 | 19 | 161 | 2 | GO_0030728 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.91e-03 | 200 | 161 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | triglycerides to total lipids in IDL percentage | 4.98e-03 | 63 | 161 | 3 | EFO_0022329 | |
| Disease | chronic kidney disease (is_marker_for) | 5.27e-03 | 20 | 161 | 2 | DOID:784 (is_marker_for) | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 5.27e-03 | 20 | 161 | 2 | OBA_2045071 | |
| Disease | esterified cholesterol measurement | 5.39e-03 | 128 | 161 | 4 | EFO_0008589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEADREPWETQDSFS | 246 | Q8N6Y0 | |
| AVWSQRPFSDLEDLE | 31 | A6NGE7 | |
| SQSRWEISTEQEPED | 131 | Q8NDB2 | |
| PRQAEDLGWSSSEFE | 161 | Q9HCE6 | |
| QLWPESSTSDVVRDD | 606 | O94986 | |
| SWEFPESSSSEEEEN | 276 | P51813 | |
| TWTEQPEAESSQADR | 1761 | P16157 | |
| VSAFDSDSIPSWSRF | 3426 | Q6V0I7 | |
| WSSRPSEVSEALFQA | 266 | Q8TCU4 | |
| RSLSATDIEVFWASP | 811 | Q8IWV2 | |
| DDSWRTGESSLPFES | 616 | O60706 | |
| WSNVNESEPSFEATR | 731 | O60706 | |
| DSFWNPNAFETDSDL | 241 | O00213 | |
| ESSRQVTSESQEEPW | 466 | Q8IYM0 | |
| DSWPTSDDEDLNFDT | 256 | Q9UPS8 | |
| LSQDDSQPWTSDETV | 26 | Q8N126 | |
| EADFSSWTPLEFLVE | 196 | P09417 | |
| SEDEAWPSLFDTFVE | 261 | Q8IWE4 | |
| DTTSSDDFDWPRIVL | 836 | Q96BY7 | |
| PDALNIENSDSESWT | 136 | Q96DT6 | |
| AEPQEFWVDNSTSVS | 286 | P01019 | |
| WINEPLSDSESEDER | 626 | O14617 | |
| ATSDQEESVAWALAP | 121 | Q8NCD3 | |
| TSDFDFELEPDDWTT | 61 | Q2T9L4 | |
| AFTPDWESREVSTGT | 21 | P28072 | |
| PEEVWATSADRYTDV | 311 | Q9HCM3 | |
| FQTERRESWSSAPEL | 591 | Q96JH8 | |
| VDSSLWSDLSSDAQE | 811 | Q8N1W1 | |
| ERTPSFTSEWEEIDK | 771 | Q7Z6G8 | |
| AAEREVSVPTFSWEE | 11 | O95864 | |
| SIPDFTAFTTVDDWL | 906 | P54762 | |
| PEVAEDGESWLSRFS | 211 | Q5T3U5 | |
| FSTEDSSAAWEQSLL | 91 | P01566 | |
| ESTENLVPFLDTWDS | 101 | O60309 | |
| SPEEITSLWSELFNS | 3001 | Q9NU22 | |
| ERSLTAGLEFWSEDT | 296 | Q8TD90 | |
| SESRSPLEDETDNTW | 1671 | Q9BY89 | |
| ESTENLVPFLDTWDS | 101 | A6NM11 | |
| ESTENLVPFLDTWDS | 101 | A6NMS7 | |
| PEDEADEWARRSSNL | 256 | O75112 | |
| FLEELPEDNLSSWAT | 436 | Q8IU57 | |
| NSPIWDQDFLSASSR | 361 | Q92831 | |
| DFQSDSDSFNPTLWE | 436 | Q96NW7 | |
| FRSEASEWEPNAISF | 306 | Q16832 | |
| ELDSDDAIFTWPDRE | 1006 | Q8IZA0 | |
| AWTDGRQSTESETPA | 676 | Q13480 | |
| NFFTDLIQDWSSDSP | 496 | Q2LD37 | |
| SDWSESLRAQTPEEE | 306 | Q99665 | |
| WDTDPSVLQLQSDSE | 126 | O14576 | |
| RNPVFQDSWDTESSG | 96 | Q969W3 | |
| EDFQPAAASETNWES | 171 | Q9GZP0 | |
| PRAEDVDLEWFASST | 1601 | Q9Y4D7 | |
| ERYDIESDQWSTVAP | 431 | Q9P2G9 | |
| PSSSWTETDVEERVY | 221 | Q6L8Q7 | |
| DAVPSEVRDWLASTF | 91 | Q01064 | |
| SDIQSDAVPSEVRDW | 91 | Q14123 | |
| DAVPSEVRDWLASTF | 96 | Q14123 | |
| LDATIAWEASPAQES | 746 | P27815 | |
| NNFLTSSWRDDDFVP | 1156 | Q14999 | |
| FSTEDSSAAWEQSLL | 91 | P01567 | |
| EFLESDSVSVSVPWD | 1456 | P48681 | |
| DWESDRNFISTAGPL | 21 | P09848 | |
| DEASSPWSVLNAELS | 1196 | Q8IWU2 | |
| FNDSSPVVLEESWDA | 2201 | Q92616 | |
| SVTEFISREWPDSQA | 331 | P59047 | |
| DPSRDAAESSEWTLA | 541 | A6NGR9 | |
| TSDFWAALEEASRLP | 516 | Q07075 | |
| ETQEPESFSAWSDRL | 191 | Q9UBC1 | |
| LNPAFEDAWSSSDEE | 381 | Q13216 | |
| SDAWEASDQSLIASP | 201 | Q86XD5 | |
| ENASDTDRSEGLSPW | 791 | Q68CR7 | |
| DEASLAPEETTDSFW | 6 | Q9BY11 | |
| NDPIEDWSSTFRQVA | 216 | Q14397 | |
| DSVWTPDIVLFDNAD | 126 | P30532 | |
| SDWSLAPTEEERESF | 511 | Q06787 | |
| RSSWASEEEANPAAT | 1106 | P42858 | |
| STVEAYNPETDTWTR | 351 | O94889 | |
| PSDDFSAATVSWDIR | 76 | Q96BY6 | |
| QPSSSSEDSDEEWRR | 146 | Q96C57 | |
| RLQWTEVDSDSVPAF | 76 | P49918 | |
| ATADTVIIFDSDWNP | 1146 | Q12873 | |
| SPILDQEDSWRDSAS | 211 | Q6IN97 | |
| VFPRWSIEESFNLSD | 301 | Q8TF40 | |
| RLPWEDTAATEEEAS | 236 | Q96A19 | |
| AFSPSTWELTEEEEA | 121 | Q6PIV2 | |
| RTSDPDFLAAVDSWF | 146 | Q6UWU2 | |
| FTAESPSEDPTRWFT | 61 | P03951 | |
| SSSQSWEEERLFPNA | 36 | Q7Z591 | |
| WLPENRDISEDQSSA | 546 | Q7Z591 | |
| WSDSSQVSSPERDNE | 941 | Q6IMN6 | |
| NWIPADSFQDRVTSE | 356 | O00462 | |
| DSWQALSEDPAAQER | 201 | A4D2B0 | |
| DSSPDFEDTWRFLEN | 261 | O75208 | |
| LREIVETWDESSGSF | 1956 | Q02388 | |
| FSREILWSGTSESED | 131 | Q8NDH2 | |
| PIFQDSQDTEFSWSD | 31 | Q5XKR9 | |
| TRPSISEDDWKNFAE | 1241 | O43933 | |
| TWTQPFDLASTREEN | 206 | P08185 | |
| TPFSVRRSWDSLNED | 231 | Q8IY42 | |
| NDVTWSEASSPDERT | 996 | Q8NG08 | |
| FSTEDSSAAWEQSLL | 91 | P01571 | |
| ESDPVAWSDVTSFDI | 366 | P10243 | |
| VADFDETFRWPVASS | 41 | Q9HC10 | |
| QWRPEESEDYETTIS | 771 | P10586 | |
| ATQGPLAESTEDFWR | 1711 | P10586 | |
| DTDWRARPATDSFDD | 196 | P23588 | |
| PVTSDWSDYRPDSDS | 1586 | P56715 | |
| EEDFVDPWTVQTSSA | 81 | P23381 | |
| LERDPDVLDTWFSSA | 576 | Q5ST30 | |
| VAESEEDLWRSETPF | 1986 | Q5T011 | |
| STEEATRWADSFDVL | 46 | P57771 | |
| DPEWSSETDALVGSR | 201 | Q7Z7N9 | |
| ENSTSATWEEREESP | 296 | O60522 | |
| PFRAKSEESEATSWF | 1416 | O43426 | |
| SADSSENWPSEEEIR | 246 | Q9C0I9 | |
| QSFLVSDPENTTWAD | 16 | Q14596 | |
| LEESASRAPSTWEES | 76 | Q9HC36 | |
| SPSSFQFNWTEEDTD | 471 | Q53T94 | |
| PVQSLRSLDSDDFWT | 291 | Q5VZ19 | |
| EETNIFPTSWELSER | 151 | Q8N565 | |
| LSPQEWEADRETGSS | 86 | O95177 | |
| RWTKVDTIAADESFP | 151 | O15197 | |
| EPVSSRTDEAETWDV | 466 | O75603 | |
| SREVTEDAADWAPAL | 16 | O43930 | |
| SRDWELLPSAAASAE | 1796 | P48634 | |
| ATNPEDRSDSSEGWS | 591 | Q8IUH8 | |
| SDLEDNRSEDSVRPW | 311 | O43166 | |
| PDTAADLDWSNLVDA | 1671 | O43166 | |
| SVSLEDWLDFSSTNV | 211 | Q969V4 | |
| SFESLPNTETDREPW | 2646 | Q9P2P6 | |
| FSTEDSSAAWEQSLL | 91 | P05014 | |
| TARWVTNNDSFAPED | 361 | Q92966 | |
| SARFPSWVTFDDNEV | 226 | Q8WXE9 | |
| SEFWLSLDESPAAAQ | 191 | Q76KP1 | |
| ESFETSAPWDRVVDL | 526 | O00116 | |
| FSEFWDLDPEVRPTS | 81 | P02656 | |
| FDARTTPATELDAWL | 81 | Q9H3H3 | |
| DDPTSKREQWFRFST | 166 | Q96PP4 | |
| AQRGSLEEFEETPWS | 141 | Q8IXZ2 | |
| SSFTRDLWPEQDIKD | 51 | Q96N38 | |
| ESDQPLNEFWSSDSQ | 36 | Q5GAN6 | |
| SPEETSRWLRSEVEN | 386 | Q96AN5 | |
| EQVSWEESQESPLSS | 1156 | Q76I76 | |
| EAPAFTIDNRSSWEN | 66 | Q9Y5K1 | |
| EKEFELRSSWSVPDA | 336 | Q9P246 | |
| IQSWADAFRSSPDLT | 121 | O60784 | |
| EWTETFPRDFQEEST | 116 | Q8N431 | |
| DDPRDVSSQWASSVN | 156 | A6NJL1 | |
| ESTDSSIPWFLRVQE | 156 | Q86VK4 | |
| DAVNPIESLDTWTEF | 496 | P35916 | |
| SLPFTFDVERSIDDW | 321 | Q9H0D6 | |
| DAATPSRSTWEEEDS | 206 | Q92620 | |
| TEEQPVASWALSFER | 56 | O43566 | |
| SSDAVAITWADRAFP | 271 | Q8TCU3 | |
| QEDESSPWFESETQI | 601 | Q9UBS9 | |
| DLNEPSADVSSAWAQ | 606 | Q99835 | |
| ERFIKWDDETTVASP | 21 | Q00722 | |
| DLSPAEIRSSWSEAA | 41 | O00337 | |
| SSDQDTWDSLRSPGF | 616 | A8K0R7 | |
| RNPWSDSESDRSSDE | 1291 | P11388 | |
| SASPRSWDEAEAQEE | 151 | Q96S55 | |
| LWDILASDFTPDERA | 956 | Q7Z3V4 | |
| SAELSSPWAARDSEQ | 616 | Q8N398 | |
| SPWAARDSEQSTDAL | 621 | Q8N398 | |
| LDREWEEEPLSTATF | 341 | Q6P2C0 | |
| PTSRETSESWTNQDD | 21 | Q6ZS52 | |
| SVDWETVDFDSAPSI | 406 | P51687 | |
| APSNEAWDNLDSDIR | 136 | Q15063 | |
| IQAWADAFRSSPDLT | 121 | Q6ZVM7 | |
| SWRNAFANDTIPSES | 1246 | Q5T4S7 | |
| FDLSWEATSSQFRPE | 21 | Q9C0H2 | |
| NTDDFTTETLEWRLG | 166 | O14530 | |
| FAFTRDDSVPEDNIW | 56 | P48651 | |
| SVDYNTTEPAVRWDS | 441 | Q63HR2 | |
| DNESWPSTAEADRDR | 256 | Q9ULE0 | |
| EPLNTSDFSDWSSFN | 146 | O95159 | |
| DTAFSDWSDEDVPDR | 1061 | Q5T200 | |
| SRFLQSISWDPEDFE | 241 | Q9H808 | |
| LPENYTDRASESDTW | 331 | P57075 | |
| QFAEAWTPNDSSEEL | 491 | Q5FWF4 | |
| WTNRFSVPDSESSET | 751 | O60237 |